Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium EDTA versus succimer for lead poisoning from oral opium use
IRCT20180131038581N1Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of edetate calcium disodium and succimer in lead poisoning (2 arms), sponsored by Hormozgan University of Medical Sciences. Primary endpoint: Lead level. Started Oct 2018; status: completed.
02
Drugs
edetate calcium disodiumsuccimer
03
Conditions
lead poisoning
Beyond the preview
Go deeper on IRCT20180131038581N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180131038581N1.